Erratum: The role of p53 in base excision repair following genotoxic stress (Carcinogenesis (bgg186) DOI: 10.1093/carcin/bgg186);The role of p53 in base excision repair following genotoxic stress

Carcinogenesis

Volumn 25, Issue 1, 2004, Pages 11-19

  Zurer, Irit ^a   Hofseth, Lorne J ^b   Cohen, Yehudit ^a   Xu Welliver, Meng ^b   Hussain, S Perwez ^b   Harris, Curtis C ^b   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA GLYCOSYLTRANSFERASE; DOXORUBICIN; HYDROGEN PEROXIDE; MESSENGER RNA; NITRIC OXIDE; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; EXCISION REPAIR; GAMMA IRRADIATION; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; MUTAGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STABILITY; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; WILD TYPE;

EID: 0942299257     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgab028     Document Type: Erratum

References (58)

1. Schwartz,D. and Rotter,V. (1998) p53-dependent cell cycle control: response to genotoxic stress. Semin. Cancer Biol., 8, 325-336.
2. Wahl,G.M. and Carr,A.M. (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nature Cell Biol., 3, E277-286.
3. Robles,A.I. and Harris,C.C. (2001) p53-mediated apoptosis and genomic instability diseases. Acta Oncol., 40, 696-701.
4. Schwartz,D., Goldfinger,N., Kam,Z. and Rotter,V. (1999) p53 controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis. Cell Growth Differ., 10, 665-675.
5. Offer,H., Milyavsky,M., Erez,N., Matas,D., Zurer,I., Harris,C.C. and Rotter,V. (2001) Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene, 20, 581-589.
6. Ford,J.M. and Hanawalt,P.C. (1997) Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem., 272, 28073-28080.
7. Janus,F., Albrechtsen,N., Dornreiter,I., Wiesmuller,L., Grosse,F. and Deppert,W. (1999) The dual role model for p53 in maintaining genomic integrity. Cell Mol. Life Sci., 55, 12-27.
8. Wang,X.W., Yeh,H., Schaeffer,L. et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet., 10, 188-195.
9. Robles,A.I., Wang,X.W. and Harris,C.C. (1999) Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene, 18, 4681-4688.
10. Jayaraman,J. and Prives,C. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81, 1021-1029.
11. Lee,S., Elenbaas,B., Levine,A. and Griffith,J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81, 1013-1020.
12. Reed,M., Woelker,B., Wang,P., Wang,Y., Anderson,M.E. and Tegtmeyer,P. (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl Acad. Sci. USA, 92, 9455-9459.
13. Janus,F., Albrechtsen,N., Knippschild,U., Wiesm ller,L., Grosse,F. and Deppert,W. (1999) Different regulation of the p53 core domain activities 3′-to-5′ exonuclease and sequence-specific DNA binding [In Process Citation]. Mol. Cell. Biol., 19, 2155-2168.
14. Appella,E. and Anderson,C.W. (2000) Signaling to p53: breaking the posttranslational modification code. Pathol. Biol., 48, 227-245.
15. Banin,S., Moyal,L., Shieh,S. et al.. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science, 281, 1674-1677.
16. Offer,H., Wolkowicz,R., Matas,D., Blumenstein,S., Livneh,Z. and Rotter,V. (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett., 450, 197-204.
17. Zhou,J., Ahn,J., Wilson,S.H. and Prives,C. (2001) A role for p53 in base excision repair. EMBO J., 20, 914-923.
18. Seo,Y.R., Fishel,M.L., Amundson,S., Kelley,M.R. and Smith,M.L. (2002) Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene, 21, 731-737.
19. Offer,H., Zurer,I., Banfalvi,G., Reha'k,M., Falcovitz,A., Milyavsky,M., Goldfinger,N. and Rotter,V. (2001) p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res., 61, 88-96.
20. Nilsen,H. and Krokan,H.E. (2001) Base excision repair in a network of defence and tolerance. Carcinogenesis, 22, 987-998.
21. Mitra,S., Boldogh,I., Izumi,T. and Hazra,T.K. (2001) Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ. Mol. Mutagen., 38, 180-190.
22. Nakamura,J. and Swenberg,J.A. (1999) Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res., 59, 2522-2526.
23. Evans,A.R., Limp-Foster,M. and Kelley,M.R. (2000) Going APE over ref-1. Mutat. Res., 461, 83-108.
24. Glassner,B.J., Rasmussen,L.J., Najarian,M.T., Posnick,L.M. and Samson,L.D. (1998) Generation of a strong mulator phenotype in yeast by imbalanced base excision repair. Proc. Natl Acad. Sci. USA, 95, 9997-10002.
25. Glassner,B.J., Posnick,L.M. and Samson,L.D. (1998) The influence of DNA glycosylases on spontaneous mutation. Mutat. Res., 400, 33-44.
26. Xiao,W. and Samson,L. (1993) In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc. Natl Acad. Sci. USA, 90, 2117-2121.
27. Kastan,M.B., Onyekwere,O., Sidransky,D., Vogelstein,B. and Craig,R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
28. Xia,F., Wang,X., Wang,Y.H., Tsang,N.M., Yandell,D.W., Kelsey,K.T. and Liber,H.L. (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55, 12-15.
29. Chen,Y., Chen,P.-L., Arnaiz,N., Goodrich,D. and Lee,W.-H. (1991) Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene, 6, 1799-1805.
30. Offer,H., Erez,N., Zurer,I., Tang,X., Milyavsky,M., Goldfinger,N. and Rotter,V. (2002) The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis, 23, 1025-1032.
31. Smith,M.L., Chen,I.T., Zhan,Q., O'Connor,P.M. and Fornace,A.J.,Jr (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene, 10, 1053-1059.
32. Drummond,J.T., Anthoney,A., Brown,R. and Modrich,P. (1996) Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem., 271, 19645-10648.
33. Lage,H. and Dietel,M. (1999) Involvement of the DNA mismatch repair system in antineoplastic drug resistance. J. Cancer Res. Clin. Oncol., 125, 156-165.
34. Jaiswal,M., LaRusso,N.F., Nishioka,N., Nakabeppu,Y. and Gores,G.J. (2001) Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res., 61, 6388-6633.
35. Mates,M. (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology, 153, 83-104.
36. Hofseth,L.J., Saito,S., Hussain,S.P. et al. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl Acad. Sci. USA, 100, 143-148.
37. Nguyen,T., Brunson,D., Crespi,C.L., Penman,B.W., Wishnok,J.S. and Tannenbaum, S.R. (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl Acad. Sci. USA, 89, 3030-3034.
38. Aloni-Grinstein,R., Zan-Bar,I., Alboum,I., Goldfinger,N. and Rotter,V. (1993) Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8, 3297-3305.
39. McCafferty,D.M., Miampamba,M., Sihota,E., Sharkey,K.A. and Kubes,P. (1999) Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut, 45, 864-873.
40. Zingarelli,B., Szabo,C. and Salzman,A.L. (1999) Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut, 45, 199-209.
41. Lane,D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
42. Bates,S. and Vousden,K.H. (1996) p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-19.
43. Kaufmann,W.K. and Paules,R.S. (1996) DNA damage and cell cycle checkpoints. FASEB J., 10, 238-247.
44. Gottlieb,T.M. and Oren,M. (1998) p53 and apoptosis. Semin. Cancer Biol., 8, 359-368.
45. Levine,J.A. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
46. Almog,N. and Rotter,V. (1997) Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta, 1333, F1-27.
47. Seluanov,A., Gorbunova,V., Falcovitz,A., Sigal,A., Milyavsky,M., Zurer,I., Shohat,G., Goldfinger,N. and Rotter,V. (2001) Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol. Cell. Biol., 21, 1552-1564.
48. Loeb,L.A. (1994) Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res., 54, 5059-5063.
49. Smith,M.L., Ford,J.M., Hollander,M.C., Bortnick,R.A., Amundson,S.A., Seo,Y.R., Deng,C.X., Hanawalt,P.C. and Fornace,A.J.,Jr (2000) p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21 and/or gadd45 genes. Mol. Cell. Biol., 20, 3705-3714.
50. Hollander,M.C., Kovalsky,O., Salvador,J.M., Kim,K.E., Patterson,A.D., Haines,D.C. and Fornace,A.J.,Jr (2001) Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res., 61, 2487-2491.
51. Engelward,B.P., Dreslin,A., Christensen,J., Huszar,D., Kurahara,C. and Samson,L. (1996) Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J., 15, 945-952.
52. Allan,J.M., Engelward,B.P., Dreslin,A.J., Wyatt,M.D., Tomasz,M. and Samson,L.D. (1998) Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res., 58, 3965-3973.
53. Posnick,L.M. and Samson,L.D. (1999) Unbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli. J. Bacteriol., 181, 6763-6771.
54. Sobol,R.W., Watson,D.E., Nakamura,J. et al. (2002) Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc. Natl Acad. Sci. USA, 99, 6860-6865.
55. Ibeanu,G., Hartenstein,B., Dunn,W.C., Chang,L.Y., Hofmann,E., Coquerelle,T., Mitra,S. and Kaina,B. (1992) Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis, 13, 1989-1995.
56. Friedberg,E.C. and Meira,L.B. (2000) Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 4. Mutat. Res., 459, 243-274.
57. Vogelstein,B., Lane,D. and Levine,A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
58. Bates,S. and Vousden,K.H. (1999) Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci., 55, 28-37